REGN Stock: A Cautionary Tale

Outlook: Regeneron Pharmaceuticals Inc. Common Stock is assigned short-term B1 & long-term B2 estimated rating.
AUC Score : What is AUC Score?
Short-Term Revised¹ :
Dominant Strategy : Speculative Trend
Time series to forecast n: for Weeks²
Methodology : Deductive Inference (ML)
Hypothesis Testing : Pearson Correlation
Surveillance : Major exchange and OTC

¹The accuracy of the model is being monitored on a regular basis.(15-minute period)

²Time series is updated based on short-term trends.

Summary

Regeneron Pharmaceuticals Inc. Common Stock prediction model is evaluated with Deductive Inference (ML) and Pearson Correlation^1,2,3,4 and it is concluded that the REGN stock is predictable in the short/long term. Deductive inference is a type of reasoning in which a conclusion is drawn based on a set of premises that are assumed to be true. In machine learning (ML), deductive inference can be used to create models that can make predictions about new data based on a set of known rules. Deductive inference is a supervised learning algorithm, which means that it requires labeled data to train. The labeled data is used to train the model to make predictions about new data. There are many different types of deductive inference algorithms, including decision trees, rule-based systems, and expert systems. Each type of algorithm has its own strengths and weaknesses. According to price forecasts for 3 Month period, the dominant strategy among neural network is: Speculative Trend

Key Points

1. Technical Analysis with Algorithmic Trading
2. Trust metric by Neural Network
3. Can stock prices be predicted?

REGN Target Price Prediction Modeling Methodology

We consider Regeneron Pharmaceuticals Inc. Common Stock Decision Process with Deductive Inference (ML) where A is the set of discrete actions of REGN stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.^1,2,3,4

F(Pearson Correlation)^5,6,7= $\begin{array}{cccc}{p}_{\mathrm{a}1}& p_{\mathrm{a}2}& \dots & p_{1n}\\ & ⋮\\ p_{j1}& p_{j2}& \dots & p_{jn}\\ & ⋮\\ p_{k1}& p_{k2}& \dots & p_{kn}\\ & ⋮\\ p_{n1}& p_{n2}& \dots & p_{nn}\end{array}$ X R(Deductive Inference (ML)) X S(n):→ 3 Month $\sum _{i=1}^n\left(r_i\right)$

n:Time series to forecast

p:Price signals of REGN stock

j:Nash equilibria (Neural Network)

k:Dominated move

a:Best response for target price

Deductive Inference (ML)

Deductive inference is a type of reasoning in which a conclusion is drawn based on a set of premises that are assumed to be true. In machine learning (ML), deductive inference can be used to create models that can make predictions about new data based on a set of known rules. Deductive inference is a supervised learning algorithm, which means that it requires labeled data to train. The labeled data is used to train the model to make predictions about new data. There are many different types of deductive inference algorithms, including decision trees, rule-based systems, and expert systems. Each type of algorithm has its own strengths and weaknesses.

Pearson Correlation

Pearson correlation, also known as Pearson's product-moment correlation, is a measure of the linear relationship between two variables. It is a statistical measure that assesses the strength and direction of a linear relationship between two variables. The sign of the correlation coefficient indicates the direction of the relationship, while the magnitude of the correlation coefficient indicates the strength of the relationship. A correlation coefficient of 0.9 indicates a strong positive correlation, while a correlation coefficient of 0.2 indicates a weak positive correlation.

 

For further technical information as per how our model work we invite you to visit the article below: 

How do AC Investment Research machine learning (predictive) algorithms actually work?

REGN Stock Forecast (Buy or Sell)

Sample Set: Neural Network
Stock/Index: REGN Regeneron Pharmaceuticals Inc. Common Stock
Time series to forecast: 3 Month

According to price forecasts, the dominant strategy among neural network is: Speculative Trend

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

Financial Data Adjustments for Deductive Inference (ML) based REGN Stock Prediction Model

1. The business model may be to hold assets to collect contractual cash flows even if the entity sells financial assets when there is an increase in the assets' credit risk. To determine whether there has been an increase in the assets' credit risk, the entity considers reasonable and supportable information, including forward looking information. Irrespective of their frequency and value, sales due to an increase in the assets' credit risk are not inconsistent with a business model whose objective is to hold financial assets to collect contractual cash flows because the credit quality of financial assets is relevant to the entity's ability to collect contractual cash flows. Credit risk management activities that are aimed at minimising potential credit losses due to credit deterioration are integral to such a business model. Selling a financial asset because it no longer meets the credit criteria specified in the entity's documented investment policy is an example of a sale that has occurred due to an increase in credit risk. However, in the absence of such a policy, the entity may demonstrate in other ways that the sale occurred due to an increase in credit risk.
2. Credit risk analysis is a multifactor and holistic analysis; whether a specific factor is relevant, and its weight compared to other factors, will depend on the type of product, characteristics of the financial instruments and the borrower as well as the geographical region. An entity shall consider reasonable and supportable information that is available without undue cost or effort and that is relevant for the particular financial instrument being assessed. However, some factors or indicators may not be identifiable on an individual financial instrument level. In such a case, the factors or indicators should be assessed for appropriate portfolios, groups of portfolios or portions of a portfolio of financial instruments to determine whether the requirement in paragraph 5.5.3 for the recognition of lifetime expected credit losses has been met.
3. When assessing a modified time value of money element, an entity must consider factors that could affect future contractual cash flows. For example, if an entity is assessing a bond with a five-year term and the variable interest rate is reset every six months to a five-year rate, the entity cannot conclude that the contractual cash flows are solely payments of principal and interest on the principal amount outstanding simply because the interest rate curve at the time of the assessment is such that the difference between a five-year interest rate and a six-month interest rate is not significant. Instead, the entity must also consider whether the relationship between the five-year interest rate and the six-month interest rate could change over the life of the instrument such that the contractual (undiscounted) cash flows over the life of the instrument could be significantly different from the (undiscounted) benchmark cash flows. However, an entity must consider only reasonably possible scenarios instead of every possible scenario. If an entity concludes that the contractual (undiscounted) cash flows could be significantly different from the (undiscounted) benchmark cash flows, the financial asset does not meet the condition in paragraphs 4.1.2(b) and 4.1.2A(b) and therefore cannot be measured at amortised cost or fair value through other comprehensive income.
4. An entity is not required to restate prior periods to reflect the application of these amendments. The entity may restate prior periods if, and only if, it is possible without the use of hindsight. If an entity does not restate prior periods, the entity shall recognise any difference between the previous carrying amount and the carrying amount at the beginning of the annual reporting period that includes the date of initial application of these amendments in the opening retained earnings (or other component of equity, as appropriate) of the annual reporting period that includes the date of initial application of these amendments.

*International Financial Reporting Standards (IFRS) adjustment process involves reviewing the company's financial statements and identifying any differences between the company's current accounting practices and the requirements of the IFRS. If there are any such differences, neural network makes adjustments to financial statements to bring them into compliance with the IFRS.

REGN Regeneron Pharmaceuticals Inc. Common Stock Financial Analysis*

Rating	Short-Term	Long-Term Senior
Outlook*	B1	B2
Income Statement	Caa2	Baa2
Balance Sheet	Baa2	Ba3
Leverage Ratios	Caa2	Caa2
Cash Flow	Ba1	C
Rates of Return and Profitability	B3	Caa2

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

Conclusions

Regeneron Pharmaceuticals Inc. Common Stock is assigned short-term B1 & long-term B2 estimated rating. Regeneron Pharmaceuticals Inc. Common Stock prediction model is evaluated with Deductive Inference (ML) and Pearson Correlation^1,2,3,4 and it is concluded that the REGN stock is predictable in the short/long term. According to price forecasts for 3 Month period, the dominant strategy among neural network is: Speculative Trend

Prediction Confidence Score

Trust metric by Neural Network: 92 out of 100 with 551 signals.

References

1. Thompson WR. 1933. On the likelihood that one unknown probability exceeds another in view of the evidence of two samples. Biometrika 25:285–94
2. G. Theocharous and A. Hallak. Lifetime value marketing using reinforcement learning. RLDM 2013, page 19, 2013
3. Challen, D. W. A. J. Hagger (1983), Macroeconomic Systems: Construction, Validation and Applications. New York: St. Martin's Press.
4. Robins J, Rotnitzky A. 1995. Semiparametric efficiency in multivariate regression models with missing data. J. Am. Stat. Assoc. 90:122–29
5. Nie X, Wager S. 2019. Quasi-oracle estimation of heterogeneous treatment effects. arXiv:1712.04912 [stat.ML]
6. M. L. Littman. Markov games as a framework for multi-agent reinforcement learning. In Ma- chine Learning, Proceedings of the Eleventh International Conference, Rutgers University, New Brunswick, NJ, USA, July 10-13, 1994, pages 157–163, 1994
7. S. Proper and K. Tumer. Modeling difference rewards for multiagent learning (extended abstract). In Proceedings of the Eleventh International Joint Conference on Autonomous Agents and Multiagent Systems, Valencia, Spain, June 2012

Frequently Asked Questions

Q: What is the prediction methodology for REGN stock?
A: REGN stock prediction methodology: We evaluate the prediction models Deductive Inference (ML) and Pearson Correlation
Q: Is REGN stock a buy or sell?
A: The dominant strategy among neural network is to Speculative Trend REGN Stock.
Q: Is Regeneron Pharmaceuticals Inc. Common Stock stock a good investment?
A: The consensus rating for Regeneron Pharmaceuticals Inc. Common Stock is Speculative Trend and is assigned short-term B1 & long-term B2 estimated rating.
Q: What is the consensus rating of REGN stock?
A: The consensus rating for REGN is Speculative Trend.
Q: What is the prediction period for REGN stock?
A: The prediction period for REGN is 3 Month

People also ask

⚐ What are the top stocks to invest in right now?
☵ What happens to stocks when they're delisted?